FILTER

Refine your search with the following facets to narrow down your results.

7 Current news of ChemDiv

Successful Milestone in Lead Discovery Collaboration with Nerviano Medical Sciences

03-Mar-2009 - ChemDiv, Inc. announced that it has earned the successful milestone in its Lead Discovery collaboration with Nerviano Medical Sciences (NMS). In October 2007, ChemDiv and NMS expanded their partnership to discover and develop potential anticancer agents. Under the terms of the collaboration, ...

biology lead discovery medicinal chemistry +3

ChemDiv and Avineuro Extend Collaboration on Alzheimer's Disease and Schizophrenia

26-Nov-2008 - ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of their research and development collaboration including formulation, safety and early clinical development studies in areas of neurodegenerative and psychiatric disorders. R&D services will be provided by Chemical Diversity ...

Alzheimer's disease psychiatric disorders schizophrenia +1

Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.

08-Oct-2008 - Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. (ChemDiv), a privately-owned,California-based discovery services company announced that they entered into an exclusive agreement for a license to Oncalis a family of PI3K inhibitors. ONC-201, the first ...

biotechnology clinical trials inflammation +5

Syndexa Pharmaceuticals and ChemDiv announce discovery collaboration

30-Apr-2008 - ChemDiv, Inc. and Syndexa Pharmaceuticals Corporation have announced the signing of a collaborative discovery research agreement. Under the terms of the agreement, ChemDiv will discover small molecule ligands for biotargets nominated by Syndexa. Financial terms of the collaboration were not ...

biology chemistry ligands +1

ChemDiv to Supply Italien Nerviano Medical Sciences with Discovery Chemical Libraries

04-Jul-2006 - ChemDiv, Inc. and Nerviano Medical Sciences (NervianoMS), Milano, Italy, announced an extension of their collaboration to an additional 2 year program. NervianoMS will use services of ChemDiv for building and enriching its portfolio of proprietary discovery chemical libraries. Such compound ...

chemistry combinatorial chemistry contract synthesis +5

ChemDiv and Berlex Announce Lead Compound Discovery Collaboration

14-Mar-2006 - ChemDiv, Inc. announced that it has entered into a discovery research collaboration with Berlex Inc., a U.S. affiliate of Schering AG, Germany. The partners will work on the discovery of potential new lead compounds against several selected GPCR targets. Under the terms of the collaboration, ...

Germany medicinal chemistry research collaborations +1

ChemDiv, Inc. and ProQinase GmbH to Partner in Lead Discovery and Preclinical Development in Oncology

08-Nov-2005 - ChemDiv, Inc. and ProQinase GmbH Germany, announced that they have signed an agreement to establish a partnership in the discovery and preclinical development of new kinase inhibitors. Under the agreement ChemDiv will support design and synthesis of target-focused small molecule libraries, ...

Formation kinase inhibitors lead discovery +4